ReviewBJPsych open2026

Efficacy, safety and policy implications of anti-amyloid monoclonal antibodies for Alzheimer's disease: protocol for a living systematic review and meta-analysis.

Saehyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.